 risk advers event children treatment acut lymphoblast leukemia jude total therapi studi viii IX frequenc predictor advers event patient treatment acut lymphoblast leukemia consecut total therapi studi vii IX event-fre surviv studi overal studi viii IX log-rank test studi patient therapi studi viii IX risk advers event first year complet therapi similar confid interv studi studi viii IX bone marrow testicular cn relaps major failur group studi studi viii IX late advers event hematolog relaps develop solid tumor black race anterior mediastin mass risk failur complet treatment clinic trial leukem cell dna content dna index predictor late treatment failur recent trial none present featur eg age leukocyt count sex valu predictor late failur thu treatment impact specif prognost factor distribut site relaps risk delay failur